STM
Journals
—
Open Access
Special Issue
Topic

Chemotherapy Adverse Effects

Guest Editor:

        • Abstract Submission Deadline : 30/11/2023

        Manuscript Submission Deadline : 25/12/2023

        [This article belongs to Special Issue Chemotherapy Adverse Effects under section rrjooh, rrjooh in (rrjooh, rrjooh)]

        Special Issue Description

        Cancer is an illness brought about by an uncontrolled division of abnormal cells in a part of the body. There are various techniques for therapy relying upon organ type, phase of cancer, state of cells, and disease as the subsequent driving reason for death around the world. Chemotherapy is a standard methodology of cancer therapy that utilizes substance specialists or medications to obliterate disease cells in the cell cycles or use synthetics or medications to restrain malignant cells’ development and spread. Chemotherapy is an essential therapy methodology for some tumors and advancing new anti-cancer drugs addresses one of the biggest drug improvement areas. Chemotherapy has its benefits and faults as the treatment influences both the physiological and mental parts of human existence. i.e., torment, rest unsettling influences, sickness, vomiting, stress, nervousness, gastrointestinal issues, bleeding, easy bruising, mouth sores, fever, etc. Chemotherapy medications can likewise cause incidental effects that don’t become apparent until months or years after treatment. Late secondary effects change contingent upon the chemotherapy drug however can include damage to lung tissue, heart problems, infertility, kidney problems, nerve damage (peripheral neuropathy), and risk of second cancer. New ways to deal with further develop resilience and diminish disease chemotherapy are direly required. Chemotherapy-induced peripheral neuropathy (CIPN) is brought about by numerous anti- malignant growth drugs including platinum-based specialists, vinca alkaloids, taxanes, and proteasome and angiogenesis inhibitors.

        Editor Keywords

        Cancer, Chemotherapy, Drugs, Chemotherapy-induced peripheral neuropathy (CIPN), Infertility

        Manuscript Submission information

        Manuscripts should be submitted online by registering and logging in to this link. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed.
        Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent on email address:[email protected] for announcement on this website.

        Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page.

        Participating journals:

        Journal Name

        Research & Reviews: Journal of Oncology and Hematology, Research & Reviews: Journal of Oncology and Hematology

        Abbrivation

        rrjooh, rrjooh

        ISSN

        2319-3387, 2319-3387

        Since

        2012

        APC

        950  $